General Information

Subsidy Information and Financing Scheme
MAF

Eltrombopag Tablet 25 mg, 50 mg


1) Treatment of immune thrombocytopenia lasting six months or longer from diagnosis in patients who...
Drug Guidance for Subsidy

04/01/2022 Eltrombopag for treating immune thrombocytopenia and severe aplastic anaemia

The Ministry of Health’s Drug Advisory Committee has recommended:

Eltrombopag 25 mg and 50 mg ...

General Availability in Public Healthcare Institution
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration

Registered Product(s) Information

Please select a product for clinical info:

Please select a Registered Product for product info.